October 3rd, 2012
ACC Fellows in Training Push Congress for Sustainable Health Care Reform
Michael Tempelhof, MD MSc
Dr. Michael Tempelhof, one of the ACC’s Fellows in Training, discusses the group’s efforts to lobby Congress for a restructured health care program, emphasizing high-quality, evidence-based medicine.
October 2nd, 2012
Long-Term Use of Beta-Blockers Questioned in Certain Patients
Sripal Bangalore, MD, MHA
Dr. Sripal Bangalore discusses his JAMA study, which found beta-blocker use was not associated with a reduced rate of cardiovascular eventsin patients who have, or are at risk for, stable coronary artery disease.
October 2nd, 2012
Registry Study Raises Questions About Cardioprotective Effect of Beta-Blockers
Larry Husten, PHD
Although beta-blockers have been a cornerstone of therapy for patients with coronary artery disease for more than a generation, a new study in JAMA suggests that that in the modern era, beta-blockers might not improve outcomes. Sriapl Bangalore and colleagues analyzed data from 44,708 patients enrolled in the Reduction of Atherothrombosis for Continued Health (REACH […]
October 1st, 2012
Selections from Richard Lehman’s Literature Review: October 1st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include exercise and mortality in those with diabetes, BP targets in those with type-2 diabetes, and the diagnostic accuracy of FFR from CT angiography.
October 1st, 2012
I Want Some of What the American Heart Association is Smoking
Yoni Freedhoff, MD
When it comes to public-private partnerships between health organizations and the food industry, there are many shades of grey — but Cheetos orange isn’t one of them.